Edward M. Kaye MD - 25 May 2022 Form 4 Insider Report for Stoke Therapeutics, Inc. (STOK)

Role
CEO, Director
Signature
/s/ Stephen Tulipano, Attorney-in-Fact
Issuer symbol
STOK
Transactions as of
25 May 2022
Net transactions value
+$9,000
Form type
4
Filing time
26 May 2022, 17:16:41 UTC
Previous filing
11 May 2022
Next filing
17 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction STOK Common Stock Options Exercise $9,000 +15,000 +150% $0.6000* 25,000 25 May 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction STOK Employee Stock Option (right to buy) Options Exercise $0 -15,000 -2.4% $0.000000 622,801 25 May 2022 Common Stock 15,000 $0.6000 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vested as to 1/4th of the total shares on October 17, 2018, and then 1/48th of the total shares vest monthly thereafter, subject to the reporting person's continued service to the issuer through each vesting date.